Instituto Nacional de Enfermedades Respiratorias   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Mexico City Mexico (1936)

Organization Overview

First Clinical Trial
2007
NCT00293228
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Instituto Nacional de Enfermedades Respiratorias